APPEAL‐1: A multiple country European survey assessing the psychosocial impact of peanut allergy

dc.contributor.authorDunn Galvin, Audrey
dc.contributor.authorBlumchen, Katharina
dc.contributor.authorTimmermans, Frans
dc.contributor.authorRegent, Lynne
dc.contributor.authorSchnadt, Sabine
dc.contributor.authorPodestà, Marcia
dc.contributor.authorSánchez, Ángel
dc.contributor.authorCouratier, Pascale
dc.contributor.authorFeeney, Mary
dc.contributor.authorHjorth, Betina
dc.contributor.authorPatel, Ram
dc.contributor.authorLush, Tessa
dc.contributor.authorRyan, Robert
dc.contributor.authorVereda, Andrea
dc.contributor.authorFernández‐Rivas, Montserrat
dc.contributor.authorFisher, Helen R.
dc.contributor.funderAimmune Therapeutics, United Statesen
dc.date.accessioned2020-05-28T10:23:01Z
dc.date.available2020-05-28T10:23:01Z
dc.date.issued2020-05-13
dc.description.abstractBackground: Peanut allergy (PA) is a common, potentially life‐threatening, and typically lifelong condition with a significant burden of illness. However, information is lacking on how persons with PA (PwPA) and their caregivers perceive the psychosocial impact of living with PA. The Allergy to Peanuts imPacting Emotions And Life study 1 (APPEAL‐1) survey, conducted across Europe, investigated the experience and impact of living with PA. Here, we report data evaluating the psychosocial impact of PA on PwPA and their caregivers. Methods: APPEAL‐1 was an online survey conducted in 8 European countries. Representatives of 8 patient advocacy groups and 5 healthcare‐research specialists developed the survey. Eligible respondent groups included: adults diagnosed with PA (self‐report); parent/nonparent caregivers (proxy‐report for a child with PA); and parent/nonparent caregivers (self‐report of PA impact on themselves). Results: Of 1846 total study respondents, 419 were adults with PA (self‐report); 546 were parents/ caregivers (proxy‐report) ; 881 were parents/caregivers (self‐report). Most respondents reported lifestyle restrictions regarding food (84‐93%) and additional domains including parties and socializing, holiday activities and destinations, and taking public transport (53‐89%). Approximately 40% rated themselves as “very” frustrated and “very” stressed. Two‐thirds (65%) felt socially isolated; 43% were bullied. Less than half felt confident in knowing when to use an adrenaline autoinjector. Several intercountry differences were observed such as high levels of uncertainty and stress in respondents from Ireland, highest rates of anxiety in respondents from Germany, and social exclusion and isolation most common in respondents from France. Conclusions: PA imposes an adverse psychosocial impact on patients and caregivers, leading to frustration, stress, and isolation. Attention to the impact of PA is needed in research and clinical practice to improve PA healthcare and public education programs.en
dc.description.statusPeer revieweden
dc.description.versionAccepted Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationDunn Galvin, A., Blumchen, K., Timmermans, F., Regent, L., Schnadt, S., Podestà, M., Sánchez, Á., Couratier, P., Feeney, M., Hjorth, B., Patel, R., Lush, T., Ryan, R., Vereda, A., Fernández‐Rivas, M. and Fisher, H. R. (2020) ‘APPEAL‐1: A multiple country European survey assessing the psychosocial impact of peanut allergy’, Allergy. doi: 10.1111/all.14363en
dc.identifier.doi10.1111/all.14363en
dc.identifier.eissn1398-9995
dc.identifier.issn0105-4538
dc.identifier.journaltitleAllergyen
dc.identifier.urihttps://hdl.handle.net/10468/10075
dc.language.isoenen
dc.publisherJohn Wiley & Sons, Inc.en
dc.rights© 2020, John Wiley & Sons, Inc. This is the peer reviewed version of the following article: Dunn Galvin, A., Blumchen, K., Timmermans, F., Regent, L., Schnadt, S., Podestà, M., Sánchez, Á., Couratier, P., Feeney, M., Hjorth, B., Patel, R., Lush, T., Ryan, R., Vereda, A., Fernández‐Rivas, M. and Fisher, H. R. (2020) ‘APPEAL‐1: A multiple country European survey assessing the psychosocial impact of peanut allergy’, Allergy, doi: 10.1111/all.14363, which has been published in final form at https://doi.org/10.1111/all.14363. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.en
dc.subjectBullyingen
dc.subjectCopingen
dc.subjectDaily lifeen
dc.subjectPeanut allergyen
dc.subjectPsychosocial impactsen
dc.titleAPPEAL‐1: A multiple country European survey assessing the psychosocial impact of peanut allergyen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
all.14363 (2).pdf
Size:
11.96 MB
Format:
Adobe Portable Document Format
Description:
Accepted Version
Loading...
Thumbnail Image
Name:
all14363-sup-0001-supinfo.docx
Size:
40.59 KB
Format:
Microsoft Word XML
Description:
Supporting Information
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description: